Media coverage
6
Media coverage
Title Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer’s Media name/outlet Business Wire Country/Territory United States Date 28/02/24 URL ct.moreover.com/?a=53204424705&p=1gw&v=1&x=IUNSuOWKIIjHnjlWuKlkNw Persons Ana Pereira Title Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's; Giovanni Frisoni, MD joins SAB comprised of prominent global Alzheimer's, neuromodulation and neuroscience experts including J Media name/outlet Business Wire Country/Territory United States Date 28/02/24 Persons Ana Pereira Title Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer’s Media name/outlet Morningstar.com Country/Territory United States Date 28/02/24 URL ct.moreover.com/?a=53204469628&p=1gw&v=1&x=fUKaZeAjZLmKFxZ2yhPwhg Persons Ana Pereira Title Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer’s Media name/outlet BioSpace Country/Territory United States Date 28/02/24 URL ct.moreover.com/?a=53204616322&p=1gw&v=1&x=8tOIp4wvY29BBV1zmd_Wpg Persons Ana Pereira Title Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer’s Media name/outlet Yahoo! Finance Country/Territory United States Date 28/02/24 URL ct.moreover.com/?a=53204461342&p=1gw&v=1&x=xWod44ZWaE_96vFAXRokEQ Persons Ana Pereira Title Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's Media name/outlet Le Lezard.com Country/Territory Canada Date 28/02/24 URL ct.moreover.com/?a=53204473099&p=1gw&v=1&x=SyGmuzZ_Sla0JQMWUx_Zcg Persons Ana Pereira